Morpholino

MO1-caspa

ID

ZDB-MRPHLNO-120808-1

Name

MO1-caspa

Previous Names

None

Target

caspa (1)

Sequence

5' - GCCATGTTTAGCTCAGGGCGCTGAC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-caspa

Expressed Gene	Anatomy	Figures
runx1	hematopoietic multipotent progenitor cell	Fig. 2 from Frame et al., 2020

Phenotype

Phenotype resulting from MO1-caspa

Phenotype	Fish	Figures
ceratohyal cartilage deformed, abnormal	WT + MO1-caspa	Fig. 8 from Masumoto et al., 2003
ceratohyal cartilage inverted, abnormal	WT + MO1-caspa	Fig. 8 from Masumoto et al., 2003
embryonic viscerocranium morphogenesis disrupted, abnormal	WT + MO1-caspa	Fig. 8 from Masumoto et al., 2003
hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal	WT + MO1-caspa	Fig. 2 from Frame et al., 2020
hematopoietic multipotent progenitor cell decreased amount, abnormal	la2Tg + MO1-caspa	Fig. 2 from Frame et al., 2020
Meckel's cartilage decreased thickness, abnormal	WT + MO1-caspa	Fig. 8 from Masumoto et al., 2003
Meckel's cartilage deformed, abnormal	WT + MO1-caspa	Fig. 8 from Masumoto et al., 2003
palatoquadrate cartilage decreased thickness, abnormal	WT + MO1-caspa	Fig. 8 from Masumoto et al., 2003
palatoquadrate cartilage deformed, abnormal	WT + MO1-caspa	Fig. 8 from Masumoto et al., 2003
pharyngeal arch cartilage disorganized, abnormal	WT + MO1-caspa	Fig. 8 from Masumoto et al., 2003
whole organism viability, abnormal	WT + MO1-caspa	text only from Masumoto et al., 2003

Phenotype of all Fish created by or utilizing MO1-caspa

Phenotype	Fish	Conditions	Figures
defense response to bacterium increased efficacy, abnormal	AB/TL + MO1-caspa	bacterial treatment by injection: Mycobacterium marinum	Fig. 6 from Zhang et al., 2020
ceratohyal cartilage deformed, abnormal	WT + MO1-caspa	standard conditions	Fig. 8 from Masumoto et al., 2003
hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal	WT + MO1-caspa	standard conditions	Fig. 2 from Frame et al., 2020
pharyngeal arch cartilage disorganized, abnormal	WT + MO1-caspa	standard conditions	Fig. 8 from Masumoto et al., 2003
ceratohyal cartilage inverted, abnormal	WT + MO1-caspa	standard conditions	Fig. 8 from Masumoto et al., 2003
hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal	WT + MO1-caspa	chemical treatment by environment: glucose	Fig. 2 from Frame et al., 2020
embryonic viscerocranium morphogenesis disrupted, abnormal	WT + MO1-caspa	standard conditions	Fig. 8 from Masumoto et al., 2003
Meckel's cartilage decreased thickness, abnormal	WT + MO1-caspa	standard conditions	Fig. 8 from Masumoto et al., 2003
palatoquadrate cartilage deformed, abnormal	WT + MO1-caspa	standard conditions	Fig. 8 from Masumoto et al., 2003
whole organism viability, abnormal	WT + MO1-caspa	standard conditions	text only from Masumoto et al., 2003
Meckel's cartilage deformed, abnormal	WT + MO1-caspa	standard conditions	Fig. 8 from Masumoto et al., 2003
palatoquadrate cartilage decreased thickness, abnormal	WT + MO1-caspa	standard conditions	Fig. 8 from Masumoto et al., 2003
hematopoietic multipotent progenitor cell decreased amount, abnormal	la2Tg + MO1-caspa	standard conditions	Fig. 2 from Frame et al., 2020
defense response to bacterium decreased efficacy, ameliorated	dram1^ibl53/ibl53 + MO1-caspa (AB/TL)	bacterial treatment by injection: Mycobacterium marinum	Fig. 6 from Zhang et al., 2020

Citations